11-108250683-CTTTTTTT-CTTTTT

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong

The NM_000051.4(ATM):​c.1236-4_1236-3delTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00452 in 1,476,638 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). The gene ATM is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0050 ( 0 hom. )

Consequence

ATM
NM_000051.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.211

Publications

10 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP6
Variant 11-108250683-CTT-C is Benign according to our data. Variant chr11-108250683-CTT-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1209911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.1236-4_1236-3delTT
splice_region intron
N/ANP_000042.3
ATM
NM_001351834.2
c.1236-4_1236-3delTT
splice_region intron
N/ANP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.1236-17_1236-16delTT
intron
N/AENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.1236-17_1236-16delTT
intron
N/AENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.1236-17_1236-16delTT
intron
N/AENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.000218
AC:
31
AN:
142218
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0000779
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000701
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000204
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00101
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000259
Gnomad OTH
AF:
0.000514
GnomAD2 exomes
AF:
0.00999
AC:
1632
AN:
163404
AF XY:
0.0101
show subpopulations
Gnomad AFR exome
AF:
0.00764
Gnomad AMR exome
AF:
0.0101
Gnomad ASJ exome
AF:
0.0109
Gnomad EAS exome
AF:
0.00898
Gnomad FIN exome
AF:
0.0116
Gnomad NFE exome
AF:
0.00970
Gnomad OTH exome
AF:
0.0114
GnomAD4 exome
AF:
0.00498
AC:
6646
AN:
1334404
Hom.:
0
AF XY:
0.00493
AC XY:
3278
AN XY:
665096
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00690
AC:
207
AN:
29998
American (AMR)
AF:
0.00854
AC:
326
AN:
38180
Ashkenazi Jewish (ASJ)
AF:
0.00618
AC:
148
AN:
23930
East Asian (EAS)
AF:
0.00470
AC:
176
AN:
37440
South Asian (SAS)
AF:
0.00564
AC:
438
AN:
77644
European-Finnish (FIN)
AF:
0.00517
AC:
196
AN:
37890
Middle Eastern (MID)
AF:
0.00262
AC:
12
AN:
4578
European-Non Finnish (NFE)
AF:
0.00473
AC:
4869
AN:
1029250
Other (OTH)
AF:
0.00494
AC:
274
AN:
55494
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.249
Heterozygous variant carriers
0
956
1912
2869
3825
4781
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000218
AC:
31
AN:
142234
Hom.:
0
Cov.:
0
AF XY:
0.000263
AC XY:
18
AN XY:
68550
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000777
AC:
3
AN:
38604
American (AMR)
AF:
0.0000701
AC:
1
AN:
14268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3394
East Asian (EAS)
AF:
0.000204
AC:
1
AN:
4890
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4506
European-Finnish (FIN)
AF:
0.00101
AC:
8
AN:
7956
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
0.000260
AC:
17
AN:
65500
Other (OTH)
AF:
0.000512
AC:
1
AN:
1952
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.309
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0123
Hom.:
575

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Familial colorectal cancer type X (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34325032; hg19: chr11-108121410; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.